Caffeine facilitation of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) through activation protein kinase C pathway: An interaction with presynaptic adenosine A1 receptors

Synapse

Volumn 61, Issue 6, 2007, Pages 401-411

  Wang, Su Jane ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Adenosine A1 receptors; Caffeine; Cerebrocortical synaptosomes; Glutamate exocytosis; PKC

Indexed keywords

4 AMINOPYRIDINE; ADENOSINE A1 RECEPTOR; CAFFEINE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM ION; GLUTAMIC ACID; IONOMYCIN; NEUROTRANSMITTER; OMEGA CONOTOXIN; POTASSIUM CHLORIDE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; MALE; MEMBRANE POTENTIAL; NERVE ENDING; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

4-AMINOPYRIDINE; ANIMALS; CAFFEINE; CALCIUM; CALCIUM SIGNALING; CEREBRAL CORTEX; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; MALE; PHOSPHODIESTERASE INHIBITORS; POTASSIUM CHANNEL BLOCKERS; PRESYNAPTIC TERMINALS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

EID: 34147134487     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20384     Document Type: Article

References (41)

1. Aigner TG. 1995. Pharmacology of memory: Cholinergic-glutamatergic interactions. Curr Opin Neurobiol 5:155-160.
2. 2(5). J Neurochem 48:552-559.
3. Angelucci ME, Vital MA, Cesario C, Zadusky CR, Rosalen PL, Da CC. 1999. The effect of caffeine in animal models of learning and memory. Eur J Pharmacol 373:135-140.
4. Barrie AP, Nicholls DG, Sanchez-Prieto J, Sihra TS. 1991. An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes. J Neurochem 57:1398-1404.
5. Bekkers JM, Stevens CF. 1990. Presynaptic mechanism for long-term potentiation in the hippocampus. Nature 346:724-729.
6. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361:31-39.
7. Dall'Igna OP, Porciuncula LO, Souza DO, Cunha RA, Lara DR. 2003. Neuroprotection by caffeine and adenosine A2A receptor blockade of β-amyloid neurotoxicity. Br J Pharmacol 138:1207-1209.
8. Davis JM, Zhao Z, Stock HS, Mehl KA, Buggy J, Hand GA. 2003. Central nervous system effects of caffeine and adenosine on fatigue. Am J Physiol Regul Integr Comp Physiol 284:R399-R404.
9. Deslandes AC, Veiga H, Cagy M, Piedade R, Pompeu F, Ribeiro P. 2005. Effects of caffeine on the electrophysiological, cognitive and motor responses of the central nervous system. Braz J Med Biol Res 38:1077-1086.
10. Farber NB, Newcomer JW, Olney JW. 1998. The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Prog Brain Res 116:421-437.
11. Fonnum F. 1984. Glutamate: A neurotransmitter in mammalian brain. J Neurochem 42:1-11.
12. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. 1999. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83-133.
13. Gevaerd MS, Takahashi RN, Silveira R, Da CC. 2001. Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats. Brain Res Bull 55:101-106.
14. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
15. Heatherley SV, Hayward RC, Seers HE, Rogers PJ. 2005. Cognitive and psychomotor performance, mood, and pressor effects of caffeine after 4, 6 and 8 h caffeine abstinence. Psychopharmacology 178:461-470.
16. Javis M. 1993. Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology 110:45-52.
17. Kaplan GB, Greenblatt DJ, Kent MA, Cotreau MM, Arcelin G, Shader RI. 1992. Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy. Neuropsychopharmacology 6:145-153.
18. Li M, West JW, Numann R, Murphy BJ, Scheuer T, Catterall WA. 1993. Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase. Science 261:1439-1442.
19. Lipton SA, Rosenberg PA. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622.
20. Loke WH. 1988. Effects of caffeine on mood and memory. Physiol Behav 44:367-372.
21. Lorist MM, Tops M. 2003. Caffeine, fatigue, and cognition. Brain Cogn 53:82-94.
22. Maia L de MA. 2002. Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 9:377-382.
23. Martin ED, Buno W. 2003. Caffeine-mediated presynaptic long-term potentiation in hippocampal CA1 pyramidal neurons. J Neurophysiol 89:3029-3038.
24. Meldrum B, Garthwaite J. 1990. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379-387.
25. Morrison JH, Patrick RH. 1997. Life and death of neurons in the aging brain. Science 278:412-419.
26. Nehlig A, Daval JL, Debry G. 1992. Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17:139-170.
27. Nicholls DG. 1993. The glutamatergic nerve terminal. Eur J Biochem 212:613-631.
28. Nicholls DG, Sihra TS. 1986. Synaptosomes possess an exocytotic pool of glutamate. Nature 321:772-773.
29. Nicholls DG, Sihra TS, Sanchez-Prieto J. 1987. Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem 49:50-57.
30. Popoli P, Reggio R, Pezzola A, Fuxe K, Ferre S. 1998. Adenosine A1 and A2A receptor antagonists stimulate motor activity: Evidence for an increased effectiveness in aged rats. Neurosci Lett 251:201-204.
31. + channels of the mammalian brain. FASEB J 5:164-170.
32. Reid CA, Dixon DB, Takahashi M, Bliss TV, Fine A. 2004. Optical quantal analysis indicates that long-term potentiation at single hippocampal mossy fiber synapses is expressed through increased release probability, recruitment of new release sites, and activation of silent synapses. J Neurosci 24:3618-3626.
33. Riedel W, Hogervorst E, Leboux R, Verhey F, van PH, Jolles J. 1995. Caffeine attenuates scopolamine-induced memory impairment in humans. Psychopharmacology (Berl) 122:158-168.
34. Sihra TS, Nichols R.A. 1993. Mechanisms in the regulation of neurotransmitter release from brain nerve terminals: Current hypotheses. Neurochem Res 18:47-58.
35. 2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release. J Biol Chem 267:1983-1989.
36. Stevens CF, Sullivan JM. 1998. Regulation of the readily releasable vesicle pool by protein kinase C. Neuron 21:885-893.
37. Svenningsson P, Nomikos GG., Ongini E, Fredholm BB. 1997. Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79:753-764.
38. 2+ and glutamate release. J Neurochem 53:1693-1699.
39. Turner TJ, Dunlap K. 1995. Pharmacological characterization of presynaptic calcium channels using subsecond biochemical measurements of synaptosomal neurosecretion. Neuropharmacology 34:1469-1478.
40. Vazquez E, Sanchez-Prieto J. 1997. Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals. Eur J Neurosci 9:2009-2018.
41. Wu LG, Saggau P. 1994. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12:1139-1148.